Reynal Vicente 4
4 · Ingersoll Rand Inc. · Filed Feb 5, 2026
Research Summary
AI-generated summary of this filing
Ingersoll Rand CEO Reynal Vicente Exercises Options and Sells Shares
What Happened
Reynal Vicente — Chairman, President and CEO of Ingersoll Rand (IR) — exercised 100,000 stock options (fully vested) and immediately sold the 100,000 shares. He exercised 9,719 shares on 2026-02-03 for $10.61/share (cost $103,119) and 90,281 shares on 2026-02-04 for $10.61/share (cost $957,881). He sold the same total 100,000 shares in open-market transactions on 2026-02-03 and 2026-02-04 for aggregate proceeds of approximately $9,754,366 (individual sales ranged from $94.00 to $99.13 per share).
Key Details
- Transaction dates: Exercises on 2026-02-03 and 2026-02-04; sales on 2026-02-03 and 2026-02-04. Filing date: 2026-02-05 (Form 4 accession 0001140361-26-003935).
- Exercise cost: ~ $1,061,000 total (100,000 shares × $10.61).
- Sale proceeds: ~ $9.75 million total for 100,000 shares (weighted prices across multiple trades; ranges noted in footnotes: $94.00–$99.13).
- Shares owned after the transactions: Not specified in the provided summary of the filing.
- Notable footnotes: Sales were made pursuant to a Rule 10b5-1 trading plan adopted May 22, 2025 (F1). Options exercised are fully vested and exercisable (F11). Several sale price entries are weighted averages across multiple trades (F2–F7). Some holdings are reported as held in trusts for family members (F8–F10).
- Timeliness: Form filed on 2026-02-05 covering trades on Feb 3–4; appears to have been filed in the standard window (not flagged as late).
Context
This was an options exercise followed by immediate open‑market sales (a common cashless-style outcome: exercise then sale). The presence of a 10b5-1 plan indicates the sales were pre‑arranged. Such transactions are typically liquidity or tax-related and, by themselves, do not necessarily indicate a change in the insider’s view of the company.
Insider Transaction Report
Form 4
Reynal Vicente
DirectorSee Remarks
Transactions
- Exercise/Conversion
Common Stock
2026-02-03$10.61/sh+9,719$103,119→ 202,905 total - Sale
Common Stock
[F1][F2]2026-02-03$94.00/sh−9,719$913,625→ 193,186 total - Exercise/Conversion
Common Stock
2026-02-04$10.61/sh+90,281$957,881→ 283,467 total - Sale
Common Stock
[F1][F3]2026-02-04$95.32/sh−2,715$258,783→ 280,752 total - Sale
Common Stock
[F1][F4]2026-02-04$96.44/sh−4,564$440,134→ 276,188 total - Sale
Common Stock
[F1][F5]2026-02-04$97.50/sh−37,618$3,667,717→ 238,570 total - Sale
Common Stock
[F1][F6]2026-02-04$98.50/sh−39,585$3,899,241→ 198,985 total - Sale
Common Stock
[F1][F7]2026-02-04$99.13/sh−5,799$574,866→ 193,186 total - Exercise/Conversion
Stock Options (Right to Buy)
[F11]2026-02-03−9,719→ 296,027 totalExercise: $10.61Exp: 2026-05-10→ Common Stock (9,719 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
[F11]2026-02-04−90,281→ 205,746 totalExercise: $10.61Exp: 2026-05-10→ Common Stock (90,281 underlying)
Holdings
- 147,802(indirect: See footnote)
Common Stock
[F8] - 75,000(indirect: See footnote)
Common Stock
[F9] - 22,500(indirect: See footnote)
Common Stock
[F10]
Footnotes (11)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2025.
- [F10]Held in a trust for the benefit of the Reporting Person's spouse and descendants.
- [F11]These stock options are fully vested and exercisable.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.00 to $94.02, inclusive. The Reporting Person undertakes to provide to Ingersoll Rand Inc., any security holder of Ingersoll Rand Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.99, inclusive. The Reporting Person undertakes to provide to Ingersoll Rand Inc., any security holder of Ingersoll Rand Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.00 to $96.97, inclusive. The Reporting Person undertakes to provide to Ingersoll Rand Inc., any security holder of Ingersoll Rand Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.03 to $97.99, inclusive. The Reporting Person undertakes to provide to Ingersoll Rand Inc., any security holder of Ingersoll Rand Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.00 to $98.99, inclusive. The Reporting Person undertakes to provide to Ingersoll Rand Inc., any security holder of Ingersoll Rand Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.00 to $99.40, inclusive. The Reporting Person undertakes to provide to Ingersoll Rand Inc., any security holder of Ingersoll Rand Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]Held in a trust for the benefit of the Reporting Person and his spouse.
- [F9]Held in a trust for the benefit of the Reporting Person's descendants.
Signature
/s/ Andrew Schiesl, as Attorney-in-Fact|2026-02-05